( OTC-QB:CELZ, OTC-PINK:CELZ )

News from Creative Medical Technology Holdings, Inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

May 23, 2018, 13:25 ET CaverStem™ Adult Stem Cell Therapy for Erectile Dysfunction Receives Positive Reception at International Urology Conference

Creative Medical Technology Holdings (OTCQB:CELZ) announced today completion of its 3 day exhibition at the American Urology Association (AUA)...


May 08, 2018, 09:15 ET Creative Medical Technology Holdings Files Patent on Anti-aging Technology Using AmnioStem Stem Cells

Creative Medical Technology Holdings announced today filing of patent application number 62663912 covering the use of its AmnioStemTM stem cells as...


May 08, 2018, 09:15 ET "Urologist to the Stars" Dr. Alexander Gershman to attend American Urological Association conference to discuss the CaverStem™ Stem Cell Procedure for Drug Refractory Erectile Dysfunction

Creative Medical Technology Holdings Inc. (OTCQB ticker symbol CELZ) announced today that Dr. Alexander Gershman will attend the AUA conference on...


Apr 30, 2018, 08:30 ET Shareholder Update: Creative Medical Technology Holdings, Inc. Continues To Extinguish Debt

Creative Medical Technology Holdings, Inc. (OTCQB-CELZ) announced today that debt to two lenders in the amount of $163,000.00 has been retired. As...


Apr 23, 2018, 12:19 ET Shareholder Update: Creative Medical Technology Holdings, Inc. Continues To Extinguish Debt

Creative Medical Technology Holdings, Inc. (OTCQB-CELZ) announced today that additional debt in the amount of $332,000.00 has been...


Apr 12, 2018, 13:25 ET Creative Medical Technology Holdings to be Keynote Speaker at Gathering of Health Care Innovators

Creative Medical Technology Holdings, Inc. (OTCQB-CELZ) announced today it will be giving the Keynote Address at the Veltmeyer Health Care...


Apr 12, 2018, 11:00 ET Shareholder Update: Creative Medical Technology Holdings, Inc. Extinguishes Additional Debt With Affiliate Company Converting To Restricted Common Shares

Creative Medical Technology Holdings, Inc. (OTCQB: CELZ) announced today that debt to affiliate company Creative Medical Health, Inc. in the amount...


Apr 04, 2018, 09:15 ET Creative Medical Technology Holdings Announces Superior Immune Modulatory of AmnioStem Stem Cells Compared to other Stem Cell Types

Creative Medical Technology Holdings (OTCQB: CELZ) announced today new data demonstrating superior immune modulatory ability of its AmnioStem™ stem...


Mar 27, 2018, 14:43 ET Shareholder Update: Creative Medical Technology Holdings, Inc. Continues To Extinguish Debt

Creative Medical Technology Holdings, Inc. (OTCQB-CELZ) announced today that debt from four early round lenders totaling $255,000.00 of principal...


Mar 26, 2018, 09:25 ET Creative Medical Technology Holdings, Inc. To Unveil Its Patented CaverStem™ Procedure For Erectile Dysfunction At International Urology Conference

Creative Medical Technology Holdings, Inc. (OTCQB-CELZ) will be exhibiting it's patented CaverStemTM stem cell procedure for erectile dysfunction...


Feb 20, 2018, 07:56 ET Creative Medical Technology Holdings Licenses Intellectual Property from Internationally Renowned Neurologist and Creates Neurology Focused Stem Cell Subsidiary

Creative Medical Technology Holdings (OTCQB:CELZ) announced today the formation of CerebroStem LLC, a majority owned subsidiary focused on...


Dec 20, 2017, 09:05 ET Stem Cells as Medicine: The Promise of Universal Donor Adult Stem Cells Continues to Attract Optimism

Creative Medical Technology Holdings, Inc (OTCQB:CELZ) provides the following discussion on a recent US News and World Report article[1] addressing...


Dec 18, 2017, 08:02 ET "Urologist to the Stars" Dr. Alexander Gershman Begins Treating Patients with Patented Caverstem™ Stem Cell Procedure for Drug Refractory Erectile Dysfunction

Creative Medical Technology Holdings, Inc. (OTCQB ticker symbol CELZ) announced today initiation of patient treatments using its patented...


Dec 14, 2017, 11:41 ET Creative Medical Technology Holdings Recruits Top Urologists for Caverstem™ Stem Cell Treatment of Erectile Dysfunction

Creative Medical Technology Holdings, Inc. (OTCQB ticker symbol CELZ) announced today recruitment of leading urologists in the Southwestern United...


Oct 19, 2017, 12:41 ET Creative Medical Technology Holdings Announces Commercialization of patented Stem Cell Procedure for Erectile Dysfunction

Creative Medical Technology Holdings (OTCQB – CELZ) announced today completion of the safety data analysis on 20 patients with...


Oct 16, 2017, 08:00 ET Creative Medical Technology Holdings Expands Stem Cell Therapeutic Platform by Entry into Field of Stroke and Neurodegeneration

Creative Medical Technology Holdings (OTCQB: CELZ) announced today filing of a patent application using a combination of an FDA approved drug...


Aug 28, 2017, 07:00 ET Creative Medical Technology Holdings Achieves 100% Patient Enrollment in CaverstemTM Clinical Trial for Stem Cell Treatment of Erectile Dysfunction

Creative Medical Technology Holdings Inc. (OTCQB ticker symbol CELZ) announced today completion of enrollment in the Company's clinical trial...


Jul 25, 2017, 15:30 ET Creative Medical Technology Holdings Demonstrates AmnioStem Derived Exosomes Inhibit Glioma Growth

Creative Medical Technology Holdings, Inc. (OTCQB:CELZ), a clinical stage stem cell company, announced preclinical data showing exosomes harvested...


Jun 21, 2017, 12:10 ET Creative Medical Technology Holdings Adds Immune Modulatory Cells for Stimulation of Perispinal Angiogenesis to Induce Regeneration of Degenerated Discs

Creative Medical Technology Holdings, Inc. (the "Company") (OTCQB:CELZ) announced the filing of intellectual property covering data supporting the...


Jun 07, 2017, 14:23 ET Creative Medical Technology Holdings Develops Platform Aimed at Augmenting All Mesenchymal Stem Cell Therapies for Lower Back Pain

Creative Medical Technology Holdings, Inc. (OTCQB:CELZ) announced filing of a patent application covering synergy between intradiscal stem cell...


May 24, 2017, 15:14 ET Creative Medical Technology Holdings, Inc. Files Patent on AmnioStem™ Mediated Immune Reprogramming for Stroke

Creative Medical Technology Holdings, Inc. (OTCQB: CELZ) (the "Company") announced today the filing of a patent application covering a novel means...


May 18, 2017, 12:00 ET Creative Medical Technology Holdings to Expand into 10 Billion Dollar per Year Lower Back Pain Market with Acquisition of Issued US Stem Cell Patent

Creative Medical Technology Holdings, Inc. (OTCQB:CELZ) announced today the acquisition of issued US patent #9,598,673 covering use of various stem...


Apr 04, 2017, 17:43 ET Creative Medical Technology Holdings Files Patent on Reducing Radiation Toxicity Using AmnioStem Universal Donor Stem Cell Product

Creative Medical Technology Holdings, Inc. (OTCQB:CELZ), a clinical stage stem cell company, announced today filing of a patent application...


Mar 08, 2017, 06:00 ET Creative Medical Technology Holdings Appoints Internationally Renowned Stem Cell Pioneer as Chief Scientific Officer

Creative Medical Technology Holdings, Inc. (OTCQB: CELZ) announced today the appointment of Dr. Thomas Ichim to the position of Chief Scientific...


Feb 22, 2017, 06:00 ET Creative Medical Technology Holdings Announces Initiation of In House Research Program at San Diego BioLabs

Creative Medical Technology Holdings (the "Company") (OTCQB:CELZ) announced today expansion of its translational research program using its...